345 related articles for article (PubMed ID: 36999624)
1. Lipids and amyotrophic lateral sclerosis: A two-sample Mendelian randomization study.
Xia K; Klose V; Högel J; Huang T; Zhang L; Dorst J; Fan D; Ludolph AC
Eur J Neurol; 2023 Jul; 30(7):1899-1906. PubMed ID: 36999624
[TBL] [Abstract][Full Text] [Related]
2. Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study.
Yan Z; Xu Y; Li K; Liu L
Acta Neurol Belg; 2024 Apr; 124(2):485-494. PubMed ID: 37889424
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in targets of lipid-lowering drugs and amyotrophic lateral sclerosis risk: a Mendelian randomization study.
Li Z; Tian M; Jia H; Li X; Liu Q; Zhou X; Li R; Dong H; Liu Y
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):197-206. PubMed ID: 37688479
[TBL] [Abstract][Full Text] [Related]
4. Polygenic link between blood lipids and amyotrophic lateral sclerosis.
Chen X; Yazdani S; Piehl F; Magnusson PKE; Fang F
Neurobiol Aging; 2018 Jul; 67():202.e1-202.e6. PubMed ID: 29685649
[TBL] [Abstract][Full Text] [Related]
5. Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study.
Zeng P; Zhou X
Hum Mol Genet; 2019 Feb; 28(4):688-697. PubMed ID: 30445611
[TBL] [Abstract][Full Text] [Related]
6. The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study.
Kintu C; Soremekun O; Kamiza AB; Kalungi A; Mayanja R; Kalyesubula R; Bagaya S B; Jjingo D; Fabian J; Gill D; Nyirenda M; Nitsch D; Chikowore T; Fatumo S
EBioMedicine; 2023 Apr; 90():104537. PubMed ID: 37001235
[TBL] [Abstract][Full Text] [Related]
7. Mendelian randomization study of lipid metabolism characteristics and migraine risk.
Hong P; Han L; Wan Y
Eur J Pain; 2024 Jul; 28(6):978-986. PubMed ID: 38183343
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
[TBL] [Abstract][Full Text] [Related]
9. The association between telomere length and blood lipids: a bidirectional two-sample Mendelian randomization study.
Yang S; Wang X; Li Y; Zhou L; Guo G; Wu M
Front Endocrinol (Lausanne); 2024; 15():1338698. PubMed ID: 38863926
[TBL] [Abstract][Full Text] [Related]
10. Type 2 Diabetes Mellitus and Amyotrophic Lateral Sclerosis: Genetic Overlap, Causality, and Mediation.
Chen H; Zhang J; Wang T; Zhang S; Lai Q; Huang S; Zeng P
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4497-e4508. PubMed ID: 34171091
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between Blood Lipids and Risk of Atrial Fibrillation: Univariable and Multivariable Mendelian Randomization Analysis.
Yang S; Pudasaini R; Zhi H; Wang L
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011056
[TBL] [Abstract][Full Text] [Related]
12. Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study.
Zhang X; Geng T; Li N; Wu L; Wang Y; Zheng D; Guo B; Wang B
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615727
[TBL] [Abstract][Full Text] [Related]
13. Blood Lipids and the Risk of Colorectal Cancer: Mendelian Randomization Analyses in the Japanese Consortium of Genetic Epidemiology Studies.
Iwagami M; Goto A; Katagiri R; Sutoh Y; Koyanagi YN; Nakatochi M; Nakano S; Hanyuda A; Narita A; Shimizu A; Tanno K; Hozawa A; Kinoshita K; Oze I; Ito H; Yamaji T; Sawada N; Nakamura Y; Nakamura S; Kuriki K; Suzuki S; Hishida A; Kasugai Y; Imoto I; Suzuki M; Momozawa Y; Takeuchi K; Yamamoto M; Sasaki M; Matsuo K; Tsugane S; Wakai K; Iwasaki M
Cancer Prev Res (Phila); 2022 Dec; 15(12):827-836. PubMed ID: 36040498
[TBL] [Abstract][Full Text] [Related]
14. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis.
Gao Y; Wang T; Yu X; ; Zhao H; Zeng P
Sci Rep; 2020 Jul; 10(1):12184. PubMed ID: 32699404
[TBL] [Abstract][Full Text] [Related]
15. Role of Inflammatory Factors in Mediating the Effect of Lipids on Nonalcoholic Fatty Liver Disease: A Two-Step, Multivariable Mendelian Randomization Study.
Chen J; Zhou H; Jin H; Liu K
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297117
[TBL] [Abstract][Full Text] [Related]
16. Lipids and sudden sensorineural hearing loss: A bidirectional two-sample Mendelian randomization analysis.
Pu K; Li L; Qiu Y; Song H
Auris Nasus Larynx; 2024 Apr; 51(2):365-370. PubMed ID: 37993362
[TBL] [Abstract][Full Text] [Related]
17. Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis.
Thompson AG; Talbot K; Turner MR
J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):75-81. PubMed ID: 34518331
[TBL] [Abstract][Full Text] [Related]
18. Dietary-Derived Essential Nutrients and Amyotrophic Lateral Sclerosis: A Two-Sample Mendelian Randomization Study.
Xia K; Wang Y; Zhang L; Tang L; Zhang G; Huang T; Huang N; Fan D
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267896
[TBL] [Abstract][Full Text] [Related]
19. Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study.
Liu B; Lyu L; Zhou W; Song J; Ye D; Mao Y; Chen GB; Sun X
BMC Med; 2023 Feb; 21(1):39. PubMed ID: 36737740
[TBL] [Abstract][Full Text] [Related]
20. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
